Heaney Robert P, Dowell M Susan, Hale Cecilia A, Bendich Adrianne
Creighton University, 601 N. 30th Street, Suite 4841, Omaha, NE 68131, USA.
J Am Coll Nutr. 2003 Apr;22(2):142-6. doi: 10.1080/07315724.2003.10719287.
Calcium absorption is generally considered to be impaired under conditions of vitamin D deficiency, but the vitamin D status that fully normalizes absorption is not known for humans.
To quantify calcium absorption at two levels of vitamin D repletion, using pharmacokinetic methods and commercially marketed calcium supplements.
Two experiments performed in the spring of the year, one year apart. In the first, in which participants were pretreated with 25-hydroxyvitamin D (25OHD), mean serum 25OHD concentration was 86.5 nmol/L; and in the other, with no pretreatment, mean serum concentration was 50.2 nmol/L. Participants received 500 mg oral calcium loads as a part of a standard low calcium breakfast. A low calcium lunch was provided at mid-day. Blood was obtained fasting and at frequent intervals for 10 to 12 hours thereafter.
Relative calcium absorption at the two 25OHD concentrations was estimated from the area under the curve (AUC) for the load-induced increment in serum total calcium.
AUC(9) (+/- SEM), was 3.63 mg hr/dL +/- 0.234 in participants pretreated with 25OHD and 2.20 +/- 0.240 in those not pretreated (P < 0.001). In brief, absorption was 65% higher at serum 25OHD levels averaging 86.5 nmol/L than at levels averaging 50 nmol/L (both values within the nominal reference range for this analyte).
Despite the fact that the mean serum 25OHD level in the experiment without supplementation was within the current reference ranges, calcium absorptive performance at 50 nmol/L was significantly reduced relative to that at a mean 25OHD level of 86 nmol/L. Thus, individuals with serum 25-hydroxyvitamin D levels at the low end of the current reference ranges may not be getting the full benefit from their calcium intake. We conclude that the lower end of the current reference range is set too low.
一般认为在维生素D缺乏的情况下钙吸收会受损,但对于人类而言,能使吸收完全正常化的维生素D状态尚不清楚。
使用药代动力学方法和市售钙补充剂,量化维生素D补充至两个水平时的钙吸收情况。
在春季进行了两项相隔一年的实验。第一项实验中,参与者先用25-羟维生素D(25OHD)进行预处理,平均血清25OHD浓度为86.5 nmol/L;另一项实验未进行预处理,平均血清浓度为50.2 nmol/L。参与者作为标准低钙早餐的一部分,口服500毫克钙负荷。中午提供低钙午餐。空腹采血,并在此后10至12小时内频繁采血。
根据负荷诱导的血清总钙增量曲线下面积(AUC)估算两个25OHD浓度下的相对钙吸收。
经25OHD预处理的参与者的AUC(9)(±标准误)为3.63毫克·小时/分升±0.234,未预处理的参与者为2.20±0.240(P<0.001)。简而言之,血清25OHD水平平均为86.5 nmol/L时的吸收比平均为50 nmol/L时高65%(两个值均在此分析物的名义参考范围内)。
尽管在未补充的实验中平均血清25OHD水平在当前参考范围内,但50 nmol/L时的钙吸收性能相对于平均25OHD水平为86 nmol/L时显著降低。因此,血清25-羟维生素D水平处于当前参考范围下限的个体可能无法从其钙摄入量中获得全部益处。我们得出结论,当前参考范围的下限设定得过低。